Functional analysis of a novel antagonistic antibody against the short epitope of the α1A-adrenergic receptor

Cardiovascular Research

Volumn 93, Issue 2, 2012, Pages 280-290

  Chen, Fen ^a   Chen, Xiao ^a   Qiu, Zhihua ^a   Wang, Min ^a   Yang, Shijun ^a   Khamis, Mustafa ^a   Yu, Miao ^a   Yu, Xian ^a   Liu, Zuxia ^a   Wang, Lan ^a   Zhou, Zihua ^a   Liao, Yuhua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

1A adrenergic receptor ( 1A AR); Antibody; Hypertension; Peptide

Indexed keywords

ADRENALIN; ALPHA 1A ADRENERGIC RECEPTOR; CP 7 ANTIBODY; CPE 8 ANTIBODY; EPITOPE; KEYHOLE LIMPET HEMOCYANIN; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDE DERIVATIVE; PRAZOSIN; PROTEIN KINASE C; RECOMBINANT ANTIBODY; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; HEART MUSCLE CELL; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BINDING; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIBODIES; CALCIUM; CELLS, CULTURED; EPINEPHRINE; EPITOPES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMUNIZATION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, CARDIAC; PHENYLEPHRINE; PHOSPHORYLATION; PRAZOSIN; PROTEIN KINASE C-ALPHA; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 84862915189     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr318     Document Type: Article

References (26)

1. Kristiansen K. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 2004;103:21-80. (Pubitemid 38891912)
2. Piascik MT, Perez DM. Alpha1-adrenergic receptors: new insights and directions. J Pharmacol Exp Ther 2001;298:403-410. (Pubitemid 32673390)
3. Graham RM, Perez DM, Hwa J, Piascik MT. Alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ Res 1996;78:737-749. (Pubitemid 126424512)
4. Pedretti A, Elena Silva M, Villa L, Vistoli G. Binding site analysis of full-length alpha1a adrenergic receptor using homology modeling and molecular docking. Biochem Biophys Res Commun 2004;319:493-500. (Pubitemid 38725973)
5. Nygaard R, Frimurer TM, Holst B, Rosenkilde MM, Schwartz TW. Ligand binding and micro-switches in 7TM receptor structures. Trends Pharmacol Sci 2009;30:249-259.
6. Guimaraes S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev 2001;53: 319-356. (Pubitemid 32476119)
7. Rokosh DG, Simpson PC. Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA 2002;99:9474-9479. (Pubitemid 34764638)
8. Hein P, Michel MC. Signal transduction and regulation: are all alpha1-adrenergic receptor subtypes created equal? Biochem Pharmacol 2007;73:1097-1106. (Pubitemid 46413172)
9. Sica DA. Alpha1-adrenergic blockers: current usage considerations. J Clin Hypertens 2005;7:757-762.
10. Sanders J, Miguel RN, Furmaniak J, Smith BR. TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities. Methods Enzymol 2010;485: 393-420.
11. Liao YH, Wei YM, Wang M, Wang ZH, Yuan HT, Cheng LX. Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension. Hypertens Res 2002;25:641-646.
12. Fu ML, Herlitz H, Wallukat G, Hilme E, Hedner T, Hoebeke J et al. Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet 1994;344:1660-1663. (Pubitemid 24371095)
13. Kunigal S, Kusch A, Tkachuk N, Tkachuk S, Jerke U, Haller H et al. Monocyte-expressed urokinase inhibits vascular smooth muscle cell growth by activating Stat1. Blood 2003;102:4377-4383. (Pubitemid 37494098)
14. Nemoto S, Sheng Z, Lin A. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol Cell Biol 1998;18:3518-3526. (Pubitemid 28240524)
15. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F. Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999;99:649-654. (Pubitemid 29077363)
16. Wenzel K, Haase H, Wallukat G, Derer W, Bartel S, Homuth V et al. Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension. PLoS One 2008;3:e3742.
17. Greengrass P, Bremner R. Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors. Eur J Pharmacol 1979;55:323-326. (Pubitemid 9232801)
18. Nagatoma T, Tsuchihashi H, Sasaki S, Nakagawa Y, Nakahara H, Imai S. Displacement by alpha-adrenergic agonists and antagonists of 3H-prazosin bound to the alpha-adrenoceptors of the dog aorta and the rat brain. Jpn J Pharmacol 1985;37: 181-187. (Pubitemid 15164008)
19. Milano CA, Dolber PC, Rockman HA, Bond RA, Venable ME, Allen LF et al. Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA 1994;91: 10109-10113.
20. Kenny BA, Chalmers DH, Philpott PC, Naylor AM. Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br J Pharmacol 1995;115:981-986.
21. Natarajan AR, Rong Q, Katchman AN, Ebert SN. Intrinsic cardiac catecholamines help maintain beating activity in neonatal rat cardiomyocyte cultures. Pediatr Res 2004;56: 411-417. (Pubitemid 39128827)
22. Verlohren S, Muller DN, Luft FC, Dechend R. Immunology in hypertension, preeclampsia, and target-organ damage. Hypertension 2009;54:439-443.
23. Nussinovitch U, Shoenfeld Y. The clinical significance of anti-beta-1 adrenergic receptor autoantibodies in cardiac disease. Clin Rev Allergy Immunol 2010 [Epub ahead of print].
24. Zhou Z, Liao YH, Wei Y, Wei F, Wang B, Li L et al. Cardiac remodeling after longterm stimulation by antibodies against the alpha1-adrenergic receptor in rats. Clin Immunol 2005;114:164-173. (Pubitemid 40082382)
25. Fan LL, Ren S, Zhou H, Wang Y, Xu PX, He JQ et al. Alpha(1D)-adrenergic receptor insensitivity is associated with alterations in its expression and distribution in cultured vascular myocytes. Acta Pharmacol Sin 2009;30:1585-1593.
26. Takeichi N, Suzuki K, Okayasu T, Kobayashi H. Immunological depression in spontaneously hypertensive rats. Clin Exp Immunol 1980;40:120-126. (Pubitemid 10107976)